MarketCap
Facebook
X
TelegramAkers Biosciences, Inc. DPO Ratio 2011-2026 | AKER
Annual DPO Ratio Akers Biosciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 218 | 163 | 254 | 372 | 207 | 113 | 119 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 372 | 113 | 207 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
72.6 | $ 67.69 | -1.36 % | $ 13.5 B | USA |
 |
Glaukos Corporation
GKOS
|
61.5 | $ 122.49 | -3.05 % | $ 7.01 B | USA |
 |
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | USA |
 |
Intuitive Surgical
ISRG
|
23.9 | $ 412.02 | -3.42 % | $ 147 B | USA |
 |
Alcon
ALC
|
63.6 | $ 66.11 | -2.64 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
39.2 | $ 139.83 | -1.53 % | $ 3.45 B | USA |
 |
Repro Med Systems
KRMD
|
46.1 | $ 3.98 | -0.5 % | $ 184 M | USA |
 |
iRhythm Technologies
IRTC
|
7.87 | $ 113.94 | 0.1 % | $ 3.65 B | USA |
 |
LeMaitre Vascular
LMAT
|
13.9 | $ 92.34 | -4.4 % | $ 2.09 B | USA |
 |
Masimo Corporation
MASI
|
84.4 | $ 179.95 | - | $ 9.59 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Microbot Medical
MBOT
|
34.9 | $ 1.77 | -2.75 % | $ 81 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
91.4 | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
66.3 | $ 0.39 | 0.7 % | $ 32 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | USA |
 |
Merit Medical Systems
MMSI
|
30.3 | $ 66.99 | -0.77 % | $ 3.96 B | USA |
 |
electroCore
ECOR
|
195 | $ 9.93 | 4.31 % | $ 84.2 K | USA |
 |
Envista Holdings Corporation
NVST
|
54.2 | $ 24.06 | -2.16 % | $ 4.04 B | USA |
 |
Haemonetics Corporation
HAE
|
39.4 | $ 78.8 | 0.11 % | $ 3.72 B | USA |
 |
STERIS plc
STE
|
34.2 | $ 208.1 | -2.25 % | $ 20.4 B | USA |
 |
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
37 | $ 29.33 | -1.81 % | $ 1.45 B | USA |
 |
InfuSystem Holdings
INFU
|
59.7 | $ 8.88 | -1.66 % | $ 183 M | USA |
 |
Teleflex Incorporated
TFX
|
47.7 | $ 132.15 | -2.65 % | $ 5.9 B | USA |
 |
Utah Medical Products
UTMD
|
17.8 | $ 68.6 | 0.78 % | $ 222 M | USA |
 |
West Pharmaceutical Services
WST
|
45.7 | $ 330.92 | -1.12 % | $ 23.9 B | USA |
 |
Pulse Biosciences
PLSE
|
1.51 K | $ 24.99 | -3.03 % | $ 1.68 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
53.7 | $ 10.04 | -4.11 % | $ 2 B | USA |
 |
Retractable Technologies
RVP
|
46 | $ 0.69 | 0.31 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
35.4 | $ 61.98 | -4.65 % | $ 204 M | USA |
 |
Predictive Oncology
POAI
|
7.25 K | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
25.9 | $ 26.66 | -3.23 % | $ 1.27 B | USA |
 |
Stereotaxis
STXS
|
124 | $ 1.81 | -2.16 % | $ 165 M | USA |
 |
Baxter International
BAX
|
45.6 | $ 20.31 | 1.4 % | $ 10.4 B | USA |
 |
ResMed
RMD
|
34.9 | $ 193.57 | -1.71 % | $ 28.3 B | USA |
 |
AtriCure
ATRC
|
68.7 | $ 27.51 | 0.77 % | $ 1.31 B | USA |
 |
Harvard Bioscience
HBIO
|
42 | $ 6.2 | 2.65 % | $ 275 M | USA |
 |
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
96.2 | $ 12.28 | -0.49 % | $ 502 M | USA |
 |
Becton, Dickinson and Company
BDX
|
59.3 | $ 147.79 | -2.8 % | $ 42.5 B | USA |
 |
Nephros
NEPH
|
39.8 | $ 3.2 | -1.54 % | $ 34 M | USA |
 |
OraSure Technologies
OSUR
|
40.1 | $ 4.03 | -4.95 % | $ 296 M | USA |
 |
Repligen Corporation
RGEN
|
32.2 | $ 130.76 | 0.48 % | $ 7.35 M | USA |